China Molecular Diagnostics Market Research, Trends, Growth, Analysis and Forecast 2017-2022

China molecular diagnostics Market is growing at a fast pace owing to rising prevalence of infectious diseases and cancer cases in the region coupled with growing geriatric population. It is projected that China molecular diagnostics market will exceed US$ 1.5 Billion by the end of 2022. Molecular diagnostics are extremely effective in diagnosing and preventing diseases, offering accurate and precise healthcare interventions in the early stages of diseases.

China Molecular Diagnostics Segments Market

China molecular diagnostics market has been segmented into three major categories: Oncology Testing, Infectious Disease Testing and Genetic Disease Testing. Further, Oncology Testing has been segmented into three major categories: Breast Cancer Testing, Colorectal Cancer Testing and Prostate Cancer Testing. Infectious Disease Testing has been segmented into two major categories, namely, virology and HPV and Genetic Testing has been segmented into Blood Screening and HLA.

China Infectious Disease test market; Virology tests accounts for the highest market share. Furthermore, our analysis found that nearly 300 million molecular diagnostic tests will be performed in China by the end of 2022 of which Virology accounts for one of the most performed tests segments.

Increasing incidence of contagious diseases along with cancer cases and the rise of the private healthcare sector in China, with the development of socio-economic conditions and the growth of a wealthy middle class, has increased the quest for affordable and quality healthcare across the region are some of the contributors which are anticipated to drive the molecular diagnostics market over the forecast period.

To read the complete report, click the link below :

This is the 5th report on Molecular Diagnostics industry published by. This report titled “China Molecular Diagnostics Market, Test Volume & Forecast by Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer) Infectious Disease Test (Virology, HPV), Genetic Test (Blood Screening, HLA)” provides a comprehensive assessment of the fast–evolving, high–growth China Molecular diagnostics market. This 105 page report with 55 Figures and 14 Tables studies the China Molecular

Diagnostic market from 4 view points:

1. Market & Forecast
2. Molecular Diagnostics Segments Market & Forecast
3. Molecular Diagnostics Segments Test Volume & Forecast
4. Profiles of Select Private Clinical Labs & Diagnostic Services Companies

Segments Covered in this report are as follows:

Oncology Test Market and Volume

• Breast Cancer
• Colorectal Cancer
• Prostate Cancer

Infectious Disease Test Market and Volume

• Virology

Genetic Test Market and Volume

• Blood Screening

Key Players Analysis

• Zhejiang Di’an Diagnostics Technology Co., Ltd.
• ADICON Clinical Laboratories (Privately held)
• Guangzhou Kingmed Diagnostics Center Co. Ltd.
• Kindstar Global (Privately held)
• BGI–Shenzhen
• OriGene Technologies

Key questions answered in the study

•  What is China molecular diagnostics market size from 2011 to 2022?
•  What is China molecular diagnostics tests volume from 2011 to 2022?
•  What are China molecular diagnostics segments market & Forecast?
•  What are the growth drivers of Molecular diagnostics in China?

Table of Contents

1. Research Findings

2. China Molecular Diagnostic Market & Test Volume Forecast

3. China Molecular Diagnostic Market Share Analysis

4. China Molecular Diagnostic Volume Share (2011 – 2022)

5. Segments Test Volume – China Molecular Diagnostics

6. Segments Test Market – China Molecular Diagnostics Market (2011 – 2022)

7. China Healthcare Insurance Schemes

8. Growth Drivers

9. Challenges

Related Reports:- Diagnostics Market Reports

Contact Us
Market Reports on China

Contact No: India: +91 22 27810773

Follow us on : Twitter, Facebook, LinkedIn, Google Plus

%d bloggers like this: